Peizhi Luo
Chief Executive Officer at ADAGENE INC.
Net worth: 26 M $ as of 2024-03-30
Profile
Pei Zhi Luo is the Chairman & Chief Executive Officer of Adagene, Inc., a company he founded in 2011.
He is also the President, Director & Chief Technology Officer of Abmaxis, Inc., a company he founded in 2000.
Dr. Luo previously worked as a Director-Biologics Technology at Merck & Co., Inc. and as a Scientist at Xencor, Inc. He received his undergraduate degree from Peking University in 1986, his doctorate degree from The University of Chicago in 1995, and his graduate degree from the Chinese Academy of Sciences in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADAGENE, INC.
21.37% | 2024-01-28 | 11,622,853 ( 21.37% ) | 26 M $ | 2024-03-30 |
Peizhi Luo active positions
| Companies | Position | Start |
|---|---|---|
| ADAGENE INC. | Chief Executive Officer | 2011-10-31 |
Former positions of Peizhi Luo
| Companies | Position | End |
|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Founder | 2008-11-05 |
| XENCOR, INC. | Corporate Officer/Principal | 2000-07-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Peizhi Luo
| Peking University | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
| Chinese Academy of Sciences | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| ADAGENE INC. | Health Technology |
| Private companies | 1 |
|---|---|
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
- Stock Market
- Insiders
- Peizhi Luo
